The science of slowed gastrointestinal motility GLP-1 receptor agonists act on the gutbrain axis and are known to slow gastric emptying and overall gastrointestinal transit , contributing to early satiety and appetite suppression. As intestinal transit slows, the colon has more time to absorb water from stool , leading to hard, dry stools that are difficult to pass . Constipation is a common, dose-related adverse effect listed in FDA prescribing information for both Wegovy (semaglutide) and Zepbound (tirzepatide) and is most frequently reported during dose escalation , with improvement over time., Step-by-Step MD Protocol for Relief 1
Nutrients, 7(8), 66706687
But as youll hear tonight, breakthroughs like these are anything but overnight. Chancellor Don Elliman Michael Holers, MD, Faculty Ventures director at CU Anschutz Innovations and Smyth Professor of Rheumatology, shared a story of his own research that illustrates how far back basic science can go and how CU Anschutz is helping move its scientists ideas forward faster
For the Wegovy pill, the doses are 1.5 mg, 4 mg, 9 mg, and 25 mg
The researchers found that male subjects with acne on the face and trunk experienced a significant decline in inflammatory acne lesions in the face, as well as an improvement in quality of life as measured by DLQI [11]
With retatrutide activating GIP, individuals might torch additional fat and achieve enhanced regulation of their energy storage and utilization